 |
ADF-APO-CCN-GUC-K67-MET-MMP-MUC-RGS; HLA class I/II binding tumor associated peptides |
|---|---|
| Trade Name | |
| Orphan Indication | Renal cancer |
| USA Market Approval | USA |
| USA Designation Date | 2012-09-28 00:00:00 |
| Sponsor | Immatics Biotechnologies GmbH;Paul-Ehrlich-Strasse 15, 72072 Tubingen; |
